Restricted accessLetterFirst published online 2015-7
Multiple Recurrences of Clostridium difficile Infection Treated With Crushed Fidaxomicin Administered Through a Percutaneous Endoscopic Gastrostomy Tube
MullaneK. Fidaxomicin in Clostridium difficile infection: latest evidence and clinical guidance. Ther Adv Chronic Dis. 2014;5:69-84.
2.
DebastSBBauerMPKuijperEJ; European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2014;20:1-26.
3.
CornelyOCrookDEspositoR. Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial. Lancet Infect Dis. 2012;12:281-289.
4.
LouieTJMilerMMullaneK. Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011;364:422-431.
5.
SmeltzerSHassounA. Successful use of fidaxomicin in recurrent Clostridium difficile infection in a child. J Antimicrob Chemother. 2013;68:1688-1689.
6.
ToussevaAJacksonJDRedellM. Stability and recovery of DIFICID® (fidaxomicin) 200-mg crushed tablet preparations from three delivery vehicles, and administration of an aqueous dispersion via nasogastric tube. Drugs R D. 2014;14:309-314.
7.
MasedaEHernandez-GancedoCLopez-TofiñoASuarez-de-la RicaAGarcia-BujalanceSGilsanzF. Use of fidaxomicin through a nasogastric tube for the treatment of septic shock caused by Clostridium difficile infection in a patient with oral cancer admitted to the surgical critical care unit. Rev Esp Quimioter. 2013;26:375-377.
